Detecting and Assessing Leg and Foot Stress Fractures Using Photon Counting CT (FootPCCT)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06024798 |
Recruitment Status :
Recruiting
First Posted : September 6, 2023
Last Update Posted : March 28, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Stress Fracture Foot Stress Fracture Ankle Stress Fracture of Tibia Stress Fracture Metatarsal Lower Limb Fracture | Diagnostic Test: Photon-Counting-Computed-Tomography |
Stress fracture is caused by the mismatch between bone strength and chronical stress applied to the bone, which is insufficient to cause an acute fracture, but a stress fracture does not heal itself. One can subclassify it into fatigue fracture (overuse of a healthy bone) and insufficiency fracture (normal use of a weakened bone). Fatigue fractures usually happen in healthy athletes or military recruits, whereas insufficiency fracture appear in patients with underlying metabolic or nutritional disorder (e.g. osteoporosis). On radiographs and Computed Tomography (CT), stress fractures are defined as round or linear intracortical lucency or an intertrabecular sclerotic line, which rarely intersects the cortex. Radiograph is a cost-effective and highly available modality in detecting fractures, showing however a moderate sensitivity in detecting stress fractures: 15-35% on the initial and 30-70% on the follow-up imaging. CT, another modality highly available in most hospital settings, shows a similar moderate sensitivity of 32-38% with however a corresponding high specificity of 88-98% on initial imaging. Similar specificity values can be observed for magnetic resonance imaging (MRI) and nuclear scintigraphy. Although their availability is limited and their respective examination time is prolonged, they outperform the x-ray based technologies in term of sensitivity (68-98% MRI and 50-97% nuclear scintigraphy, respectively).
The introduction of dual-energy technology advanced CT from a pure anatomical evaluation tool to a combined anatomical and functional modality. Every material has a specific absorption number, which can be assessed by applying two different energies (high and low x-ray tube voltages). This method of multispectral imaging has been established and clinically implemented in detecting gout and characterizing renal stones. Further studies have shown that DECT can depict bone marrow edema, a marker of early stress fracture and a common finding in MRI. However, this has yet not been implemented in clinical practice.
The photon-counting-computed-tomography (PCCT) has been introduced recently, enabling an energy dependent separation of photons over the whole x-ray energy spectrum. This results in reduced background noise, improved image resolution and multispectral imaging without the necessity of an additional acquisition at a different energy level. An initial study has shown already shown the superiority of PCCT by better detecting and characterizing small renal stones, when compared to conventional dual-energy computed tomography (DECT).
In this project the investigators aim to include clinically referred patients with suspected stress fracture of the lower extremity who will have an MRI to confirm the diagnosis of a suspected stress fracture. The subjects will be scanned on the new PCCT system with dose saving technology, guaranteeing an examination according to the ALARA-principle (as low as reasonably achievable). The investigators will not inject iodine contrast media and they will expect a median dose of 2-4 mSv (millisieverts). Since this will not exceed the threshold of 5 mSv, this project will be classified as category A.
Study Type : | Observational [Patient Registry] |
Estimated Enrollment : | 50 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 13 Weeks |
Official Title: | Assessing Patients With Suspected Stress or Insufficiency Fracture of the Lower Extremity With Photon-Counting-Computed-Tomography |
Actual Study Start Date : | September 1, 2023 |
Actual Primary Completion Date : | December 31, 2023 |
Estimated Study Completion Date : | January 30, 2025 |
- Diagnostic Test: Photon-Counting-Computed-Tomography
Initial and follow up (after 4 weeks) PCCT acquisition of the affected area of the lower extremity. Image acquisition will be performed on the PCCT
- Presence of a fracture [ Time Frame: Day 1, 4weeks follow up assessment ]Presence/absence of a fracture
- Presence of bone edema [ Time Frame: Day 1, 4weeks follow up assessment ]Presence/absence of bone edema
- Presence of soft tissue edema [ Time Frame: Day1, 4weeks follow up assessment ]Presence/absence of soft tissue edema
- Pain localization [ Time Frame: Day 1, 4 weeks follow up assessment, 12 weeks follow up assessment ]Pain localization will be done through a clear statement of anatomical location
- Pain character [ Time Frame: Day 1, 4 weeks follow up assessment, 12 weeks follow up assessment ]Pain will be characterized using the following terms: sharp, dull, aching, burning, radiating, numbing, and pulsating.
- Pain intensity [ Time Frame: Day 1, 4 weeks follow up assessment, 12 weeks follow up assessment ]Pain intensity will be described using the Number Rating Scale (NRS): a score of 0 corresponds to the absence of pain, while a score of 10 indicates the most intense pain ever experienced.
- Pain duration [ Time Frame: Day 1, 4 weeks follow up assessment, 12 weeks follow up assessment ]Pain duration is described in days (d).
- Karlsson Scoring Scale: Patient reported outcome regarding the stress fracture [ Time Frame: Day 1, 4 weeks follow up assessment, 12 weeks follow up assessment ]The Karlsson scoring scale is utilized to evaluate and quantify both the functional status and the extent to which the stress fracture affects an individual's quality of life. The scoring system comprises a total of 90 points, where 0 points represent the most severe condition and 90 points indicate an absence of any issues.
- Foot Function Index: Patient reported outcome regarding the stress fracture [ Time Frame: Day 1, 4 weeks follow up assessment, 12 weeks follow up assessment ]The Foot Function Index is utilized to evaluate and quantify both the functional status and the extent to which the stress fracture affects an individual's quality of life. The minimum score is 0% (no pain or difficulty), and maximum score is 100%
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 16 Years and older (Child, Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- ≥ 16 years of age. Minor study subjects can have an additional signature by the parent or legal guardian
- Clinically suspected stress or insufficiency fracture of the lower extremity
- Written consent of study participation
- Patients who will have an MRI to confirm the diagnosis of a suspected stress fracture
Exclusion Criteria:
- < 16 years of age
- Pregnancy
- Metal implants
- Postoperative situation
- Infection or tumorous disease affecting the lower extremity
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06024798
Contact: Viehöfer Arnd, PD Dr.med. | +41 44 386 57 55 | Arnd.Viehöfer@balgrist.ch | |
Contact: Zendeli Flamur | +41 44 386 56 72 | Flamur.Zendeli@balgrist.ch |
Switzerland | |
Balgrist University Hospital | Recruiting |
Zürich, Zurich, Switzerland, 8008 | |
Contact: Stephan Wirth, PD Dr.med. +41 44 386 11 11 Stephan.Wirth@balgrist.ch |
Principal Investigator: | Stephan Wirth, PD Dr.med. | Balgrist University Hospital |
Publications:
Responsible Party: | Balgrist University Hospital |
ClinicalTrials.gov Identifier: | NCT06024798 |
Other Study ID Numbers: |
W1024 |
First Posted: | September 6, 2023 Key Record Dates |
Last Update Posted: | March 28, 2024 |
Last Verified: | March 2024 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Fractures, Bone Fractures, Stress Tibial Fractures Wounds and Injuries Leg Injuries |